Evaluation

Are former heavy drinkers in the UK less likely to identify as being in recovery compared to those in the USA? A pilot test

Citation
Cunningham, J.A., Godinho, A. Are former heavy drinkers in the UK less likely to identify as being in recovery compared to those in the USA? A pilot test. Subst Abuse Treat Prev Policy 16, 74 (2021). https://doi.org/10.1186/s13011-021-00412-8
Publication Date

The Alcoholics Anonymous (AA) movement created the term "in recovery" to express the continuing requirement for vigilance in order to sustain sobriety (which includes abstinence from alcohol intake) and avoid a return to dangerous drinking. This term, or identity, may be adopted by someone who considers themselves to be in recovery for the rest of their lives.

Psychosocial Interventions to Improve Psychological, Social and Physical Wellbeing in Family Members Affected by an Adult Relative’s Substance Use: A Systematic Search and Review of the Evidence

Citation
McGovern, R., Smart, D., Alderson, H., Araújo-Soares, V., Brown, J., Buykx, P., Evans, V., Fleming, K., Hickman, M., Macleod, J., Meier, P., & Kaner, E. (2021). Psychosocial Interventions to Improve Psychological, Social and Physical Wellbeing in Family Members Affected by an Adult Relative's Substance Use: A Systematic Search and Review of the Evidence. International journal of environmental research and public health, 18(4), 1793. https://doi.org/10.3390/ijerph18041793
Publication Date

The use of alcohol and drugs is a significant public health concern and is prevalent in families. Over 100 million people are thought to be affected by a close relative's substance use, with many experiencing negative health and social consequences. Additional associated stressors, such as interpersonal conflict, financial issues, the burden of care, and family conflict, frequently increase the multi-dimensional impact of substance use.

Reprint of: Biotechnologies and the future of opioid addiction treatments

Citation
Daniel Wolfe, Roxanne Saucier, Reprint of: Biotechnologies and the future of opioid addiction treatments, International Journal of Drug Policy, Volume 94, 2021, 103273, ISSN 0955-3959, https://doi.org/10.1016/j.drugpo.2021.103273.
Publication Date

Biotechnological treatment, including addiction treatment, is the way of the future. Researchers and pharmaceutical companies praise depot injections, agonist/antagonist implants, deep brain stimulation, and hapten conjugate vaccines as medicine's greatest chance for reducing illegal usage, reducing the danger of overdose and severe withdrawal, and preventing drug diversion to criminal markets.

Identifying content-based engagement patterns in a smoking cessation website and associations with user characteristics and cessation outcomes: a sequence and cluster analysis

Citation
Olga Perski, PhD, Noreen L Watson, PhD, Kristin E Mull, MS, Jonathan B Bricker, PhD, Identifying Content-Based Engagement Patterns in a Smoking Cessation Website and Associations With User Characteristics and Cessation Outcomes: A Sequence and Cluster Analysis, Nicotine & Tobacco Research, Volume 23, Issue 7, July 2021, Pages 1103–1112, https://doi.org/10.1093/ntr/ntab008
Publication Date

Tobacco smoking is the greatest cause of sickness and early death worldwide, with 8 million people dying each year from a smoking-related condition. The use of pharmaceutical or behavioural assistance improves smokers' chances of quitting; nonetheless, the majority of smoking cessation efforts are unassisted.

The impact of COVID-19 on drug use and harm reduction programming in the Middle East and North Africa (MENA) region: a regional consultation of stakeholders and people who use drugs

Citation
Van Hout, M.C., Haddad, P. & Aaraj, E. The Impact of COVID-19 on Drug Use and Harm Reduction Programming in the Middle East and North Africa (MENA) Region: a Regional Consultation of Stakeholders and People Who Use Drugs. Int J Ment Health Addiction (2021). https://doi.org/10.1007/s11469-021-00500-7
Publication Date

COVID-19 (SARS-CoV-2) was classified a pandemic on March 11, 2020, with early reports of the disease occurring in the Middle East and North African (MENA) area. On January 2021, the World Health Organization Eastern Mediterranean Regional Office (WHO-EMRO) reported 5,566,708 confirmed cases with 131,886 fatalities to date.

Gender disparities in opioid treatment progress in methadone versus counselling

Citation
Guerrero, E., Amaro, H., Kong, Y. et al. Gender disparities in opioid treatment progress in methadone versus counseling. Subst Abuse Treat Prev Policy 16, 52 (2021). https://doi.org/10.1186/s13011-021-00389-4
Publication Date

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.

High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder

Citation
Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. doi:10.1001/jamanetworkopen.2021.17128
Publication Date

In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.

Trends in use of e-cigarette device types and heated tobacco products from 2016 to 2020 in England

Citation
Tattan-Birch, H., Brown, J., Shahab, L. et al. Trends in use of e-cigarette device types and heated tobacco products from 2016 to 2020 in England. Sci Rep 11, 13203 (2021). https://doi.org/10.1038/s41598-021-92617-x
Publication Date

During the past decade, heated aerosolized nicotine delivery systems (HANDS) —mainly e-cigarettes—have surpassed nicotine replacement therapy as the most utilized aids for stopping smoking in England.

Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centres with SBIRT services

Citation
Watson, D.P., Staton, M.D., Dennis, M.L. et al. Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centers with SBIRT services. Subst Abuse Treat Prev Policy 16, 58 (2021). https://doi.org/10.1186/s13011-021-00381-y
Publication Date

Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low-cost treatment option for many people who misuse alcohol and drugs. Nevertheless, inconsistent BT implementation often costs similar to regular outpatient care.

Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study

Citation
Khouja JN, Wootton RE, Taylor AE, Davey Smith G, Munafò MR (2021) Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study. PLoS Med 18(3): e1003555.
Publication Date

Background:

Tobacco smoking and e-cigarette use are strongly associated, but it is currently unclear whether this association is causal, or due to shared factors that influence both behaviours such as a shared genetic liability. The aim of this study was to investigate whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes.